16
Gonorrhea Sexually Transmitted Disease Surveillance 2005 Division of STD Prevention

Gonorrhea Sexually Transmitted Disease Surveillance 2005

  • Upload
    syshe

  • View
    34

  • Download
    1

Embed Size (px)

DESCRIPTION

Gonorrhea Sexually Transmitted Disease Surveillance 2005. Division of STD Prevention. Gonorrhea — Rates: United States, 1941–2005 and the Healthy People 2010 target. Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000 population. - PowerPoint PPT Presentation

Citation preview

Page 1: Gonorrhea Sexually Transmitted Disease Surveillance 2005

GonorrheaSexually Transmitted Disease

Surveillance 2005

Division of STD Prevention

Page 2: Gonorrhea Sexually Transmitted Disease Surveillance 2005

Gonorrhea — Rates: United States, 1941–2005 and the Healthy People 2010 target

Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000 population.

Rate (per 100,000 population)

Gonorrhea2010 Target

0

100

200

300

400

500

1941 46 51 56 61 66 71 76 81 86 91 96 2001

Page 3: Gonorrhea Sexually Transmitted Disease Surveillance 2005

Gonorrhea — Rates: Total and by sex: United States, 1986–2005 and the Healthy People 2010 target

Rate (per 100,000 population)

MaleFemaleTotal2010 Target

0

90

180

270

360

450

1986 88 90 92 94 96 98 2000 02 04

Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000 population.

Page 4: Gonorrhea Sexually Transmitted Disease Surveillance 2005

Gonorrhea — Rates by region: United States, 1996–2005 and theHealthy People 2010 target

Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000 population.

Rate (per 100,000 population)

WestMidwestNortheastSouth2010 Target

0

60

120

180

240

300

1996 97 98 99 2000 01 02 03 04 05

Page 5: Gonorrhea Sexually Transmitted Disease Surveillance 2005

Gonorrhea — Rates by state: United States and outlying areas, 2005

Note: The total rate of gonorrhea for the United States and outlying areas (Guam, Puerto Rico and Virgin Islands) was 114.2 per 100,000 population. The Healthy People 2010 target is 19.0 cases per 100,000 population.

Rate per 100,000population

Guam 63.8

Puerto Rico 8.4

Virgin Is. 27.6

<=19.0

19.1-100.0

>100

(n= 7)

(n= 25)

(n= 21)

VT 9.7NH 13.6MA 39.5RI 40.5CT 78.5NJ 65.8DE 110.0MD 126.6

207.6

91.5

86.2162.6

95.7 70.1

116.3

179.6

81.1

8.5

157.5 129.8

54.4

95.270.8

212.0

10.8

174.9

68.3

247.0

164.3

17.0

66.3123.4

81.5

92.1

176.5

20.2

183.1

148.4

43.5

90.5

203.9

45.5

145.8

116.1

30.4111.9

60.3

42.4

106.5

17.2

Page 6: Gonorrhea Sexually Transmitted Disease Surveillance 2005

Gonorrhea — Rates by county: United States, 2005

Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000 population.

Rate per 100,000population

<=19.0 (n= 1,303)

19.1-100.0 (n= 1,118)

>100.0 (n= 719)

Page 7: Gonorrhea Sexually Transmitted Disease Surveillance 2005

Gonorrhea — Cases by reporting source and sex: United States, 1996–2005

Cases (in thousands)

non-STD Clinic Malenon-STD Clinic FemaleSTD Clinic MaleSTD Clinic Female

0

40

80

120

160

200

1996 97 98 99 2000 01 02 03 04 05

Page 8: Gonorrhea Sexually Transmitted Disease Surveillance 2005

Gonorrhea — Rates by race/ethnicity: United States, 1996–2005

Rate (per 100,000 population)

WhiteBlackHispanicAsian/PIAI/AN

0

180

360

540

720

900

1996 97 98 99 2000 01 02 03 04 05

Page 9: Gonorrhea Sexually Transmitted Disease Surveillance 2005

Gonorrhea — Age- and sex-specific rates: United States, 2005

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total

6.0

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total

35.2

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total

261.2

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total

624.7

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total

436.8

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total

581.2

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total

306.5

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total

277.7

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total

176.4

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total

116.5

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total

126.9

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total

62.3

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total

90.8

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total

34.0

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total

49.2

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total

12.2

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total

17.1

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total

2.5

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total

4.2

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total

0.6

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total111.8

Men Rate (per 100,000 population) Women

Age750 600 450 300 150 0 0 150 300 450 600 750

10-1415-1920-2425-2930-3435-3940-4445-5455-6465+Total 119.4

Page 10: Gonorrhea Sexually Transmitted Disease Surveillance 2005

Gonorrhea — Age-specific rates among women 15 to 44 years of age:United States, 1996–2005

Rate (per 100,000 population)

15-19 20-2425-29 30-3435-39 40-44

0

200

400

600

800

1,000

1996 97 98 99 2000 01 02 03 04 05

Page 11: Gonorrhea Sexually Transmitted Disease Surveillance 2005

Gonorrhea — Age-specific rates among men 15 to 44 years of age:United States, 1996–2005

Rate (per 100,000 population)

15-19 20-2425-29 30-3435-39 40-44

0

150

300

450

600

750

1996 97 98 99 2000 01 02 03 04 05

Page 12: Gonorrhea Sexually Transmitted Disease Surveillance 2005

Gonorrhea — Positivity among 15- to 24-year-old women tested in family planning

clinics by state: United States and outlying areas, 2005

*States/areas not meeting minimum inclusion criteria.Note: Includes states and outlying areas that reported gonorrhea positivity data on at least 500 women aged 15-24 years screened during 2005.

SOURCE: Regional Infertility Prevention Projects; Office of Population Affairs; Local and State STD Control Programs; Centers forDisease Control and Prevention

Positivity (%)

Puerto Rico 0.4

Virgin Is. 3.0

See*

<1.0

1.0-1.9

>=2.0

(n= 9)

(n= 21)

(n= 17)

(n= 6)

VT 0.1NH 0.4MARICT 0.8NJ 1.2DE 1.2MDDC 1.9

1.6

0.6

0.9 1.6

1.1 0.5

0.8

2.1

0.7

1.4 1.1

0.6

0.70.6

1.9

0.0

3.8

1.1

2.8

1.2

1.2

0.50.6

1.3

0.6

1.5

1.7

0.72.1

0.9

1.5

0.71.0

0.4

4.2

0.2

Page 13: Gonorrhea Sexually Transmitted Disease Surveillance 2005

Gonococcal Isolate Surveillance Project (GISP) — Location of participating clinics and regional laboratories: United States, 2005

STD ClinicsClinics and Regional Labs

Birmingham Phoenix

Long Beach Los Angeles

Orange Co. San Diego

San Francisco Denver

Miami

Atlanta

Honolulu

Tripler AMC

Chicago

New Orleans

Baltimore

Detroit Minneapolis

Las Vegas

Albuquerque

Greensboro

Cincinnati

Cleveland

Oklahoma City

Portland

Philadelphia

Dallas

Seattle

Page 14: Gonorrhea Sexually Transmitted Disease Surveillance 2005

Gonococcal Isolate Surveillance Project (GISP) — Penicillin and tetracycline resistance among GISP isolates, 2005

Note: PPNG=penicillinase-producing N. gonorrhoeae; TRNG=plasmid-mediated tetracycline-resistant N. gonorrhoeae; PPNG-TRNG=plasmid-mediated penicillin- and tetracycline-resistant N. gonorrhoeae; PenR=chromosomally mediated penicillin-resistant N. gonorrhoeae; TetR=chromosomally mediated tetracycline-resistant N. gonorrhoeae; CMRNG=chromosomally mediated penicillin- and tetracycline-resistant N. gonorrhoeae.

Page 15: Gonorrhea Sexually Transmitted Disease Surveillance 2005

Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates with resistance or intermediate resistance to ciprofloxacin,

1990–2005

Note: Resistant isolates have ciprofloxacin MICs ≥ 1 µg/ml. Isolates with intermediate resistance have ciprofloxacin MICs of 0.125 - 0.5 µg/ml. Susceptibility to ciprofloxacin was first measured in GISP in 1990.

Percent

Resistant

Intermediate resistance

0.0

3.0

6.0

9.0

12.0

1990 91 92 93 94 95 96 97 98 99 2000 01 02 03 04 05

Page 16: Gonorrhea Sexually Transmitted Disease Surveillance 2005

Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates with resistance to ciprofloxacin by sexual behavior,

2001–2005

Percent Ciprofloxacin Resistant

Heterosexual men

Men who have sex with men (MSM)

0

5

10

15

20

25

30

2001 2002 2003 2004 2005